Clinical trial Recruiting at 1 site Observational Ages 18 and up

Blood viscosity in ARDS: a look at how thick the blood is

Official title: Assessment of Blood Viscosity in ARDS

Run by Hospices Civils de Lyon · NCT07823296 · Data updated 2026-11-12

This study tests whether blood viscosity is higher in adults with ARDS and whether viscosity relates to their breathing and blood flow issues.

More ARDS trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment46 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Locations1 site (Lyon)
StatusRecruiting
StartedOctober 27, 2026
Main results expectedJanuary 1, 2028
Study endsJanuary 1, 2028
Registry record updatedNovember 6, 2026
Trial IDNCT07823296 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older with moderate-to-severe ARDS (PaO2/FiO2 ≤ 200 mmHg) meeting inclusion criteria and able to provide consent (patient or surrogate).

Probably not a fit

Patients with ARDS longer than 72 hours, those with recent transfusions or certain blood conditions, or those with high bleeding risk may not benefit or be excluded from the study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares blood viscosity and its determinants in adults with moderate-to-severe ARDS to a control group without ARDS. It collects blood samples from peripheral veins and from arterial/central lines to measure viscosity-related parameters. The goal is to see if hyperviscosity is present in ARDS and whether it correlates with respiratory and hemodynamic changes. The study is conducted at Hopital de la Croix-Rousse in Lyon under the Hospices Civils de Lyon as the lead sponsor. Participants include adults 18 and older with ARDS meeting specific criteria or eligible controls who consent to participate.

Why it matters

Potential benefit: If hyperviscosity is found to be linked to ARDS severity, this could inform future therapies aimed at normalizing blood viscosity to improve outcomes.

How similar studies have gone: Previous work has examined deformability in ARDS, but comprehensive blood viscosity parameter assessment in ARDS is not well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Case Group

Inclusion Criteria:

* Age ≥ 18 ans
* Moderate-to-severe ARDS according to the global definition:
* with PaO₂/FiO₂ ≤ 200 mmHg (based on arterial blood gas analysis in patients receiving invasive or non-invasive mechanical ventilation or high-flow nasal oxygen therapy).
* Participation agreement obtained (either from the patient themselves or from a relative)

Exclusion Criteria:

* ARDS that has been present for more than 72 hours
* Terminally ill patient with death expected within 24 hours
* Patient who has received a blood transfusion within the past month
* Patient with a known hematologic malignancy (lymphoma; myeloma; acute or chronic leukemia)
* Patient with a known hemoglobinopathy.
* Hemorrhagic shock
* Hemoglobin \< 70 g/dL

Control group

Inclusion Criteria:

* Age ≥ 18 ans
* Participation agreement obtained (either from the patient themselves or from a relative)

Exclusion Criteria:

* Presence of ARDS according to the global definition
* P/F \< 300 mmHg
* Presence of sepsis defined by an infection and a SOFA score delta ≥ 2.
* Terminally ill patient with death expected within 24 hours
* Patient who has received a blood transfusion within the past month
* Patient with a known hematologic malignancy (lymphoma; myeloma; acute or chronic leukemia)
* Patient with a known hemoglobinopathy.
* Hemorrhagic shock
* Hemoglobin \< 70 g/dL

Where it's running

  • Hopital de la Croix-Rousse
    Lyon, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.